Cargando…
Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study
BACKGROUND: Polycystic ovarian syndrome (PCOS) is a highly variable syndrome and one of the most common female endocrine disorders. Although the association inositols-glucomannan may represent a good therapeutic strategy in the treatment of PCOS women with insulin resistance, the effect of inositols...
Autores principales: | Troisi, Jacopo, Cinque, Claudia, Giugliano, Luigi, Symes, Steven, Richards, Sean, Adair, David, Cavallo, Pierpaolo, Sarno, Laura, Scala, Giovanni, Caiazza, Maria, Guida, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431025/ https://www.ncbi.nlm.nih.gov/pubmed/30904021 http://dx.doi.org/10.1186/s13048-019-0500-x |
Ejemplares similares
-
Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition
por: Tortolini, Cristina, et al.
Publicado: (2023) -
Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol
por: Vyas, Lila, et al.
Publicado: (2022) -
The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes
por: Pintaudi, Basilio, et al.
Publicado: (2016) -
Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review
por: Bizzarri, Mariano, et al.
Publicado: (2023) -
PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol
por: Monastra, Giovanni, et al.
Publicado: (2021)